静脉注射对比剂对双源双能CT骨密度测量的影响
回顾性纳入1031例肿瘤分期患者,比较平扫与门静脉期双源双能CT基于物质分解的腰椎松质骨体积骨密度。门静脉期与平扫BMD无显著差异(p=0.44),相关性高(r=0.971),Bland-Altman一致性极佳,平均差异0.61 mg/cm3。结论:门静脉期双源双能CT可准确机会性评估腰椎BMD。
要点
- 门静脉期双源双能CT可用于腰椎松质骨BMD机会性评估,与平扫高度一致。
- 对比剂增强不影响基于物质分解的体积BMD测量,无需额外骨密度检查。
- 肿瘤分期增强CT可同时评估BMD,减少辐射暴露和额外检查。
核心结论
- 门静脉期双源双能CT与平扫在腰椎松质骨体积BMD评估中无显著差异,相关性和一致性均高。
研究设计与样本
- 采用基于物质分解的专用后处理软件进行无体模腰椎松质骨体积BMD评估。
- 比较平扫与增强门静脉期BMD,使用Pearson相关、线性回归和Bland-Altman分析。
诊断标准与关键数值
- 平扫和增强门静脉期平均BMD分别为115.53±37.23和116.10±37.78 mg/cm3。
- 两期BMD差异无统计学意义(p=0.44),相关系数r=0.971(95%CI 0.969-0.973)。
- Bland-Altman分析平均差异0.61 mg/cm3,95%一致性界限-17.14至18.36 mg/cm3。
临床应用与阅片要点
- 在肿瘤分期增强双源双能CT门静脉期可机会性测量腰椎松质骨BMD,无需额外平扫或骨密度检查。
- 基于物质分解的后处理可用于增强期BMD评估,报告时可注明利用门静脉期机会性评估。
局限性
- 回顾性单中心设计,仅纳入肿瘤分期患者,未报告其他人群验证。
- 仅评估腰椎松质骨,未涉及其他骨骼部位或不同对比剂方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the influence of intravenously injected contrast agent on bone mineral density (BMD) assessment in dual-source dual-energy CT.
METHODS: This retrospective study included 1,031 patients (mean age, 53 ± 7 years; 519 women) who had undergone third-generation dual-source dual-energy CT in context of tumor staging between January 2019 and December 2019. Dedicated postprocessing software based on material decomposition was used for phantomless volumetric BMD assessment of trabecular bone of the lumbar spine. Volumetric trabecular BMD values derived from unenhanced and contrast-enhanced portal venous phase were compared by calculating correlation and agreement analyses using Pearson product-moment correlation, linear regression, and Bland-Altman plots.
RESULTS: Mean BMD values were 115.53 ± 37.23 and 116.10 ± 37.78 mg/cm3 in unenhanced and contrast-enhanced dual-energy CT series, respectively. Values from contrast-enhanced portal venous phase differed not significantly from those of the unenhanced phase (p = 0.44) and showed high correlation (r = 0.971 [95% CI, 0.969-0.973]) with excellent agreement in Bland-Altman plots. Mean difference of the two phases was 0.61 mg/cm3 (95% limits of agreement, -17.14 and 18.36 mg/cm3).
CONCLUSION: Portal venous phase dual-source dual-energy CT allows for accurate opportunistic BMD assessment of trabecular bone of the lumbar spine compared to unenhanced imaging. Therefore, dual-source CT may provide greater flexibility regarding BMD assessment in clinical routine and reduce radiation exposure by avoiding additional osteodensitometry examinations, as contrast-enhanced CT scans in context of tumor staging are increasingly performed in dual-energy mode.
引用
- Koch V, Albrecht MH, Gruenewald LD, et al. Impact of Intravenously Injected Contrast Agent on Bone Mineral Density Measurement in Dual-Source Dual-Energy CT. Acad Radiol. 2021. PMID: 34266738. doi:10.1016/j.acra.2021.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。